Radiotherapy and Oncology

Article	Citations
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration	200
529 Current standard of care treatment in non-metastatic cervix cancer	117
44 Ultrahypofractionated Versus Moderately Hypofractionated and Conventionally Fractionated Pelvic Radiotherapy for Prostate Cancer: Outcomes from 3 Prospective Clinical Trials	115
80 Stereotactic Body Radiation Therapy for Intrahepatic Graft Recurrence of Hepatocellular Carcinoma After Liver Transplantation	99
292 Correlation of cf DNA with response in head & neck cancer treated with definitive chemoradiotherapy	95
122 Effect of Different Treatment Planning Optimizers on Stereotactic Ablation Radiotherapy (SABR) Volumetric Modulated ARC Therapy (VMAT) Plans	94
23 Stereotactic Body Versus Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for High-Risk Prostate Cancer (HR-PC); Early Results of PBS: A Phase II Randomized Trial (NCT03380806)	88
31 Program Director Perspectives on the Implementation and Experiences of the Competence By Design Curriculum in Canadian Radiation Oncology Training Programs	86
525 Proton and carbon therapy: recent technological advances	85
33 An investigator-initiated clinical study using SBRT as “in situ vaccination”:‘R-ISV-FOLactis’trial	84
45 Stereotactic radiosurgery for tremor: a center experience.	83
207 ctDNA-based WES enhances actionable alterations detection in locally advanced head and neck cancer	77
54 Scattered Radiation to the Testis and Testosterone Secretion in Prostate Cancer Treated with Radiotherapy Alone	77
157 Adaptive radiation therapy	76
480 Addressing the education and training needs of RTT in particle radiation therapy	73
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy	67
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	67
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	65
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome	64
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	63
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study	61
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	61
3429: Modulating innate immunity by DNA damage response inhibition	59
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT	59
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	57

749: Reinforcement learning for accelerated automatic treatment planning optimization	56
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	56
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.	55
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer	55
1635: In vivo dosimetry - keeping my finger on the pulse	54
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	53
1861: Performance of a heart substructures autocontouring tool after clinical implementation	52
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT	51
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife	50
3201: Dosimetric properties of flexible 3D-printed boluses	49
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	49
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility	44
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	43
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	43
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer	43
1487: Radiotherapy access in the Asia-Pacific: Are we making progress for low- & middle-income countries?	42
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	42
2116: Outcomes of EBRT and brachytherapy in anal cancer: retrospective analysis between 2016 and 2021	40
1977: PSMA-PET and PCa: an ancillary RADIOSA study beyond a numerical definition of oligometastatic state	40
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	40
760: Dependence on the calibration field in treatment verifications using the 1600SRS liquid array	40
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	40
1006: Prediction of cisplatin tolerance during chemoradiation in older HNSCC patients: A multicenter study	39
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	39
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	39
2010: Postmastectomy radiotherapy after immediate breast reconstruction: toxicities and control rate.	39
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	39
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	39
1537: Brachytherapy efficacy and safety in the treatment of primitive tongue carcinomas	38
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	38
2026: Quantitative T1 mapping in the presence of an implantable cardiac device on a 1.5T MR-linac	38
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	38
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	38
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	37
2353: X-irradiation, but not proton, irradiation, induces an inflammatory cytokine response in saliva	37
1136: Electron beam radiotherapy for the management of perianal malignancies	36
3346: How to balance the patient and clinician needs: Are we on the same side?	36
3484: RAPTOR project: Verification	36
1651: The impact of ground-glass opacities on dose calculation accuracy for lung SBRT	35
2874: Interstitial brachytherapy in carcinoma cervix: long term results, toxicity and patterns of failure	35
512: Proton minibeam radiation therapy: elucidating in vivo mechanisms with infrared microspectroscopy	35
742: EXTREME HYPOFRACTIONATED RT FOR PROSTATE CA. Phase II. Results in toxicity and economical cost	34
2974: Generalised Competing Risk models predict relative risk of cancer events in p16+ oropharynx cancer	34
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	34
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	33
3379: Management of older patients with skin cancer: Are we overtreating?	33
1317: Identifying Lymphocyte Infiltration for Rectal Cancer Outcome Prediction Using Phase III Trial Data	33
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	33
3548: Virtual patients for clinical trials	33
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	33

1293: Immunotherapy-related hypothyroidism on head and neck cancer: impact of RT dose to the thyroid gland	33
692: T1 & T2 mapping on a Unity MRL in a clinically feasible timeframe	32
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	32
910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy	32
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study	32
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review	32
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	32
1839: Stimulation of immune response to overcome radioresistance in BRCA1 mutant breast cancer cells	31
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging	31
527: A novel integrated measure of cervical HDR brachytherapy plan quality	31
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	31
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	31
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	31
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	30
3043: Early response assessment of Ca cervix treated with PETCT based SIB-Online Adaptive Radiotherapy	30
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	30
OUTCOMES OF BRAIN METASTASIS FROM NON-SEMINOMATOUS GERM CELL TUMOUR: A POPULATION-BASED REVIEW	30
1670: Facing the climate change: is radiotherapy as green as we would? A preliminary analysis	30
2889: Risk Assessment of Patient-Specific Quality Assurance Methods for Particle Therapy	30
GETTING A HEAD START: REDUCING POST OPERATIVE RADIATION WAIT TIMES IN HEAD AND NECK CANCER	30
Response to the commentary on “Optimizing fractionation schedules for de-escalation radiotherapy in head and neck cancers using deep reinforcement learning” by Mohammad Zahid, and Heiko Enderling	29
Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy	29
OFF-PROTOCOL RADIOTHERAPY IN PROSPECTIVE SYSTEMIC THERAPY TRIALS FOR METASTATIC NON-SMALL CELL LUNG CANCER	29
Efficacy and toxicity of hyperfractionated thoracic reirradiation	29
Comprehensive summary and retrospective evaluation of prognostic scores for patients with newly diagnosed brain metastases treated with upfront radiosurgery in a modern patient collective	29
PO-1670 Initial Assessment of Adaptive Pancreas SBRT Treatment Efficiency using ViewRay MRIdian A3i	29
12 Safety and Efficacy of Stereotactic Body Radiotherapy for Ultra-Central Thoracic Tumours	28
OC-0267 Long-term results of an SBRT dose-escalation trial for bone and lymph node metastases (NCT03486431)	28
PO-1488 Local recurrence of prostate cancer after curative RT: the role of salvage SBRT re-irradiation	28
304 the Changing Landscape of Radiation Therapy: Implications for Future Planning	28
73: Erectile Function After 60 GY in 20 Fractions External Beam Radiotherapy to the Prostate	28
109: Prostate Cancer-Specific Death Rates in Localized Prostate Cancer: Data from Two Randomized Trials	28
174: Influence of Palliative Radiotherapy on Toxicity and Survival in Patients Treated with Radium-223 Dichloride for Metastatic Castrate-Resistant Prostate Cancer	28
SP-0035 From atlas-based knowledge to ML-based planning solutions	28
MO-0789 Patient experience of head and neck treatment on a 1.5T MRLinac: is our adaptive solution tolerable?	27
OC-0775 Comprehensive proton dose prediction with Bayesian LSTMs	27
PD-0231 Acute toxicity after the 5-fraction versus 15-fraction radiotherapy regimen for early breast cancer	27
PO-1886 Respiratory motion prediction based on LSTM and linear regression models	27
PO-1632 deep learning-based automatic segmentation of rectal tumors in endoscopy images	27
OC-0766 Gain from respiratory gating in left-sided partial breast irradiation in the DBCG PBI trial	27
MO-0725 Radiomics-based prediction of radiosensitivity from preclinical HNSCC histopathology imageS	26
PO-1914 Surface Guided Helical Tomotherapy for Total Marrow Irradiation	26
67: Ensuring Superior Reporting of Non-Inferiority Radiotherapy Clinical Trials: A Systematic Review	26
PO-1589 Clinical outcomes of two radiotherapy schedules for spinal cord compression	26
PO-1406 Re-irradiation in locally recurrent rectal cancer: a national survey of the AIRO GI study group	26
PO-1542 Seminal vesicle displacement with Hydrogel spacer insertion on prostate radiotherapy	26
PO-1893 Gated dynamic trajectory radiotherapy: feasibility, mechanical accuracy and dosimetric validation	26
PO-1640 MRI-based deep learning autocontouring: Evaluation and implementation for brain radiotherapy	25
MO-0148 Time trends for online adapative treatment on the 1.5T MR-Linac	25
PO-1344 Prognostic significance of platelet-to-lymphocyte ratio in hepatocellular carcinoma	25
PO-2353 Impact of Breast volume on Skin toxicities during Hypo-fractionated Radiotherapy in Breast cancer	25
PO-2166 Commissioning of new rectal applicator using electronic brachytherapy source	25
PO-1938 Organ motion in thorax and abdomen during radiotherapy: a multicenter study in 188 children	25
SP-0016 Dopamine receptor antagonists, radiation, and cholesterol biosynthesis in mouse models of glioblastoma	25
PO-1964 Towards a novel treatment plan evaluation concept in carbon ion radiotherapy based on high-LET-dose	25
OC-0449 Deep learning based NTCP-modelling using 3D-information for predicting late xerostomia	24
PO-1386 Treatment outcomes of 1.5 T MR-guided adaptive radiotherapy for locally advanced pancreatic cancer	24
PO-1350 Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT	24
PO-2282 SABR Prostate: A review of specialised techniques for motion management	24
PO-2225 Characterization of the RBE of various photon radiation qualities on human cancer cell lines	24
PD-0418 Interstitial And Surface Mold Brachytherapy For Head And Neck Cancers- An Institutional Experience	24
OC-0437 Mature outcomes for TROG 99.03: RCT of RT +/- (R)-CVP in Stage I-II Follicular Lymphoma	24
PD-0805 Inter-observer variation for national Danish contouring atlas on organs at risk in the pelvis	23
SP-1017 Proton arc therapy: Rationale and current status	23
OC-0436 A Delphi consensus study on SBRT for oligometastatic renal cell carcinoma (RCC) an ESTRO ACROP study	23
PO-1281 External validation of the MSKCC nomogram for Ductal Carcinoma in Situ and risk factors analysis	23
SP-1034 Oligometastatic renal cell carcinoma	23
OC-0466 Verification of rectal cancer target auto-contouring by trained RTTs in online adaptive MRIgRT	23
MO-0481 Towards near real-time adaptive proton therapy: the partial adaptation strategy	23
OC-0592 Patient reported quality of life during and after primary radiotherapy for prostate cancer	23
PO-1694 MRI derived brain morphometric measurements: effect of voxel size, anisotropy and slice orientation	22
MO-0390 Evaluating intra-breath-hold variation in IMAT breast boost patients delivered in DIBH	22
PD-0250 Intrafraction tumor motion monitoring and dose reconstruction for liver spot scanning proton therapy	22
OC-0942 Geometric stability during Stereotactic Arrhythmia Radiotherapy	22
OC-0933 Automatically Triggered Surface-Based RT in DIBH in Breast Cancer - SAVE HEART dosimetry report	22
206 Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT) as an Adjuvant Therapy for Non-Operative Patients or Salvaging Local Failure	22
PD-0398 Clinical outcomes of Thyroid Sparing Radical Chemoradiation in the treatment of Head and Neck cancer	22
MO-0881 Evaluation of plan-of-the-day selection in adaptive radiation therapy of cervical cancer	22
PO-2130 clinical outcomes of brachytherapy combined with applicator-guided IMRT in bulky cervical tumor	22
PD-0401 The effect of dose to the brain on early self-reported neurocognition; does low dose matter?	22

OC-0254 Feasibility of RTT-only Conebeam CT-guided online adaptive radiotherapy for bladder cancer	22
PO-1131 Proton and carbon ion therapy for intracranial meningioma after previous brain radiotherapy	22
OC-0122 Deep Learning Segmentation of Cardiac Substructures in Radiotherapy Planning	22
PO-2038 Analysis of daily treatment fractions using PerFRACTION on a Halcyon linac	22
PD-0248 Can surface imaging predict the impact of anatomical deformations on proton breast treatment?	22
PO-2245 In situ abscopal effect: synergistic efficacy of immunotherapy and partial tumor irradiation	22
MO-0951 Outcome of total body irradiation for hematopoietic stem cell transplantation conditioning	22
33 Efficacy of Ultra Hypofrationed Radiotherapy Combined with HDR Brachytherapy	22
261 A 3D Star Shot to Determine Axes of Rotation	21
PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study	21
Need for standardization in the use of structures in the intensity-modulated radiation therapy planning of head and neck cancers, a GORTEC study	21
OC-0119 Interactive deep-learning for tumour segmentation in head and neck cancer radiotherapy	21
126 Investigation of a Monte Carlo Model Based Dose Calculation for 103Pd Low Dose Rate Breast Brachytherapy	21
Moderate adverse events and regional differences in CDK4/6 inhibitor treatment combined with palliative radiotherapy	21
247 the Effect of CT Acquisition Parameters on Extracted Radiomic Features Using Computational Phantoms	21
PD-0253 Ultra-compact and highly efficient proton therapy: Design considerations and clinical simulations	21
SP-0336 Spatially-fractionated radiotherapy: Tumour-subvolumes, dose-delivery and clinical applications	21
Further Data to Support Clinical Integration of Nodal Hypofractionation: A Commentary on the FAST-Forward Nodal Sub-study	20
78 Targeting tumor-promoting myeloid cell functions in head & neck cancer	20
133: Interventions to Support Nutrition in Patients Undergoing Concurrent Chemoradiation for Esophageal Cancer: A Systematic Review of Randomized Trials	20
SP-0356 Low dose radiotherapy reverses resistance to immunotherapy: From bench to bedside	20
CNG (Collaborative Nasopharyngeal Carcinoma Group) stage: Improved prognostic stratification of nasopharyngeal carcinoma and association with Epstein-Barr virus DNA in the intensity-modulated radiatio	20
161 14-day Pathway from Decision to Treat to Radiotherapy for Head and Neck Cancer in the National Health Service: An Evaluation of Feasibility and Outcomes at Torbay Hospital.	20
PD-0663 Deep learning cycleGAN MRI-only synthetic-CT generation for pelvis, brain and head and neck cancers	20
PO-1532 Long-term outcomes of proton beam therapy for elderly patients with prostate cancer	20
179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma	20
123 Can machine-learning model predict overall survival in head and neck cancer patients?	20
PD-0962 Second PFS after post-PACIFIC relapse in the Blue Sky observational study on stage 3 NSCLC.	20
PO-1247 Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer	20
230 Body image seen by patients with nasopharyngeal cancer	19
239 Re-irradiation in head and neck cancers: Real-world experience from a tertiary cancer institute	19
3394 Use of a compression belt as a cost-effective means for reducing lung tumour motion for SBRT treatment	19
2418 Bias in radiation therapy publications	19
Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model	19
94 Influence of chemotherapy regimens prior to nivolumab on the survival of recurrent/metastatic SCCHN.	19
3574 First institutional report from Argentina on stereotactic body radiotherapy (SBRT) in patients with oligometastatic gynecologic cancer	19
244 The volumetric and dosimetric impacts of respiratory motion management in lung SBRT: A systematic review	19
4161 Capsaicin Patch Therapy for Chronic Neuropathic Pain in Breast Cancer Survivors: Importance of Early Diagnosis and Intervention	19
Radiation therapy for stage IIA/IIB seminomas: Back to the future?	19
130 head and neck rhabdomyosarcoma; clinicopathological features, trends, and role of adjuvant therapy.	19
121 Differential functional outcomes following transoral surgery for oropharyngeal carcinoma -laser versus robot	19
2426 Evaluation of an AI-based autosegmentation software for head and neck vessels contouring	19
4208 THE VALUE OF COMPLETE RESPONSE IN OLIGOMETASTASIS-DIRECTED SBRT FOR PROSTATE CANCER: A MONOINSTITUTIONAL EXPERIENCE	19
4581 Remote Dose Rate Assessment for FLASH Quality Assurance	18
4262 Internal Audit of Palliative Radiotherapy Protocols: Impact of Fractionation and 30-Day Mortality Outcomes in Advanced Cancer Patients	18
4863 How to (critically) read a paper?	18
4695 Challenges and opportunities of biomarker-directed optimisation of breast radiotherapy	18
4270 Accidental Discovery of a Unique High-Density Bolus Property Enabling Single-Step Bolus Alignment and Patient Positioning in SGRT	18
471 Quality of Life after post mastectomy chest wall radiotherapy for breast cancer (SUPREMO): 5-year followup results of a prospective randomised trial.	18
685 Quality-of-life and in-depth pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the BONY-M trial	18
4684 The next frontier with (VHE)E	18
4749 Evolving practice: How re-irradiation is shaping the role of the RTT	18
657 Breaking Barriers: Patient-related factors impacting upon radiotherapy clinical trial enrolment	18
2358 Integrating novel and classical prognostic factors in locally advanced cervical cancer: a machine learningbased predictive model (ESTHER Study).	17
3744 Feasibility of nipple-areola complex preservation in retroareolar disease: oncological outcomes and therapeutic implications	17
3276 Time Analysis of Proton Therapy Treatment Delivery for Workflow Optimization	17
872 A systematic review of pragmatic randomized controlled trials in oncology	17
873 Operable breast cancer patients who refuse surgery can be cured by definitive radiotherapy with or without radiosensitization strategy	17
3903 Association between severe adverse events and organ-at-risk dose in Stereotactic Arrhythmia Radiotherapy: a mid-term safety evaluation	17
1939 Online 2D dose verification required in UHDR-FLASH preclinical research: challenges and possibilities	17
2297 Elective nodal CTV in early anal cancer: A systematic review and meta-analysis on the risk of recurrence in the upper pelvic and external iliac LNS	17
2588 Impact of pain education on pain relief in oncological patients: an AMSTAR-compliant systematic review of systematic reviews and meta-analyses.	17
3293 Reduced CTV-to-PTV margins for online adaptive radiotherapy for prostate cancer	17
67 Comparative analysis of 3DCRT, IMRT and Helical Tomotherapy in Glioblastoma: Evaluation of recurrence dynamics	17
3817 Predicting IROC’s Thoracic Dosimetry Audit Performance Using Random Forest Modeling and Feature Interpretability.	17
3857 systematic literature review of particle therapy costing literature: a 20-years overview	17
3885 Patient specific 4D photon dose reconstruction and accumulation based on treatment log files : a framework for adaptive radiotherapy assessment	17
2109 Real-world clinical outcomes of stereotactic MR-guided adaptive radiotherapy (SMART) for localized pancreatic cancer: A retrospective cohort analysis	17
2330 An evaluation of the first advanced practice RTT in Hong Kong: specialist radiation therapist in uro-oncology	17
3877 A Deep Learning-Based Predictive Model: Can AI Accurately Predict VMAT Dose Distributions in Lung Cancer?	17
3792 Feasibility and accuracy of patient setup in gynaecological cancer treatments using Surface-Guided Radiotherapy	17
3604 Artificial Intelligence-driven failure prediction on TomoTherapy® systems	17
946 Creating a SPACE for Prostate SBRT- a Single Institution’s Pilot Study	17
769 Management of head and neck squamous cell carcinoma with N3 nodal disease	17
4928 Dose accumulation in radiotherapy of skin cancer	17
4932 ALK-driven NSCLC and radiotherapy - pro	17
2074 Clinical safety and efficacy of palliative Simultaneous Integrated Boost Lattice RT in patients with advanced cancers: A prospective analysis	17
1300 High-risk localized prostate cancer treated with risk-adapted intensification therapy: Clinical impact of radiation dose	16
1464 Tumour Response Assessment with PSMA-PET Scan (PSMA Scan) Following Stereotactic Ablative Body Radiotherapy (SABR) for Renal Cell Carcinoma (RCC)	16
4538 Adult survivors of childhood cancers: own experience	16
1754 Dose-intensified stereotactic body radiation therapy for vertebral oligometastases: results from a prospective clinical trial	16
2899 Frame induced MR distortion in Gamma Knife radiosurgery: assessment at 1.5T and 3T for two frame models	16
1419 Open or closed: a prospective, self-controlled study of the performance of two immobilisation mask types in head and neck cancer radiotherapy	16
1456 Clinical priorities-driven head and neck simultaneous integrated boost radiotherapy using deep reinforcement learning	16
4411 Hypofractionated radiotherapy for breast cancer after mastectomy : can dosimetric constraints be achieved?	16
447 IMRT by Tomotherapy with concurrent weekly cisplatin followed by Brachytherapy HDR in locally advance cervical cancer (prospective study).	16
1414 PERSONAL - Personalized extended-interval fractionated SBRT using online adaptive planning: enhancing efficacy and tolerability in metastatic patients	16
3001 Advanced MRI Perfusion Biomarkers for Predicting Relapse Sites in Grade 4 IDH-Mutant Astrocytoma and Glioblastoma	16
2738 Abdominal Compression vs Non-Abdominal Compression Planning CT for Cardiac Stereotactic Ablative Radiotherapy (cSABR)	16
4338 APRT Analysis for Online Adaptive Radiotherapy Contouring and Adaptor Model Evaluations Using Time-Driven Activity-Based Costing	16
1366 Assessing the Predictive Role of Volumetric Changes in Soft Tissue Sarcomas of the Extremities Following Neoadjuvant Radiotherapy	16
4441 Bowel function assessed using Patient Reported Outcome Measures after contact brachytherapy for rectal cancer within the CITRuS trial	16
4567 Radonek - Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation	16
2925 Optimization of External Contours in Eclipse for Surface-Guided Radiotherapy with Exactrac Dynamic	16
3170 Hypoxia region dose escalation in head and neck cancer – dosimetric analysis	16